Project Grant R03DA060283
Award Date
7/1/25
Completion Date
6/30/27
Dollars Obligated
$149K
Federal Agency
National Institute on Drug Abuse
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Eugene, OR 97403, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to investigate the impact of prenatal exposure to cannabis on childhood adiposity and cardiometabolic health outcomes. The $234,000 award, with a performance period from August 2024 to July 2026, will support a study using a well-characterized observational cohort in Colorado to measure the levels of delta-9-tetrahydrocannabinol (D9-THC) and...
This National Institute on Drug Abuse (NIDA) Project Grant award under CFDA 93.279 (Drug Use and Addiction Research Programs) provides $390,635 to the University of Pittsburgh to develop a novel intervention that addresses prenatal depressive symptoms to encourage tobacco and cannabis cessation among marginalized pregnant and postpartum people. The key products and services to be delivered through this grant include: 1) Conducting formative research on the experiences of marginalized pregnant...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support a $346,911 cross-species research study to identify early life environmental and genetic risk factors for substance use disorders (SUDs). The key objectives are to: 1) determine how early life environment influences neurocognitive development and its relationship to adult impulsivity behaviors; 2) identify genomic networks associated...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under CFDA Program 93.279 Drug Use and Addiction Research Programs, supports a 5-year, $2,726,432 study on the co-use of cannabis and prescription opioids among emerging adults (ages 18-25) in medical settings. The study will enroll emerging adults who are prescribed opioids for acute pain management and have either no lifetime history of cannabis use (5%) or recent cannabis use (95%). Participants will be...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $163,568 to Brown University to conduct a multimodal study integrating biobehavioral markers and ecological assessment of the relationship between cannabis use, trauma, and self-regulatory cognitive processes. The study aims to examine how cognitive processes related to decision-making, such as reward motivation and inhibitory control,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a research project entitled "Optimizing Developmental Outcomes in Early Childhood After Neonatal Opioid Withdrawal Syndrome." The $180,059 award, effective August 1, 2024, will fund a 5-year longitudinal study to assess the independent and moderating effects of positive childhood experiences (PCEs) and adverse childhood experiences...
This $376,078 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support research to explore the relationship between cannabis use for coping purposes and quantity/frequency of cannabis use. The 5-year study, set to commence on August 1, 2024, will be conducted by the University of Colorado. Key objectives include: Experimentally testing whether cannabis use increases after stress induction among...
This $6,439,263 federal Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 Drug Abuse and Addiction Research Programs) aims to determine the impact of maternal substance use on maternal immune activation, placental function, and offspring neurobehavioral development. The project will leverage the Healthy Brain and Child Development (HBCD) study to perform maternal immune profiling, placental and cord blood analysis, and novel neuroinflammation imaging on 400 pregnancies...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $395,995 to Oregon Health & Science University (OHSU) to conduct a longitudinal study examining the reciprocal relationships between cannabis use, sleep, and the hypothalamic-pituitary-adrenal (HPA) axis. The study will enroll 60 participants, including healthy controls and those with moderate and severe cannabis use disorder, to assess the...
This Project Grant award of $1,315,596 from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to investigate the effects of maternal exposure to electronic nicotine delivery system (ENDS) aerosols during pregnancy on addiction-related behaviors and neurobiology in offspring. The primary objectives are to examine the impacts of maternal ENDS aerosol exposure on measures of impulsivity, nicotine abuse liability, and function of...